Home > E. Pathology by systems > Respiratory system > Lungs > EGFR+ KRAS+ ALK+ pulmonary adenocarcinoma

EGFR+ KRAS+ ALK+ pulmonary adenocarcinoma

Thursday 9 January 2014

References

- Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report. Rossing HH, Grauslund M, Urbanska EM, Melchior LC, Rask CK, Costa JC, Skov BG, Sørensen JB, Santoni-Rugiu E. BMC Res Notes. 2013 Nov 26;6(1):489. doi : 10.1186/1756-0500-6-489 PMID: 24279718